Summary
To develop a HPLC-MS method of determining ginsenoside Rh2 in dog plasma based on solid-phase extraction for pharmacokinetic studies. Six dogs were randomly assigned to two groups, either given 0.1mg / kg dose intravenously or 1 mg / kg dose through oral gavage. Analysis using high performance liquid chromatography (HPLC) with ODS column, followed by detection with electrospray ionization(ESI) mass spectrometry(MS) in negative ion mode with 500 μM ammonium chloride in the mobile phase. The assays were validated over the concentration range of 2.0–1250.0 ng/ml in dog plasma. The intra- and inter- day precision were less than 10% in terms of RSD. The overall recovery was more than 80%. The validated assay was suitable for pharmacokinetic studies of ginsenoside Rh2 and the observed oral bioavailabilities of Rh2 were 17.6% and 24.8% for male and female dogs respectively.
Similar content being viewed by others
References
Cuddy ML. (2003): Commonly used herbs. J Pract Nurs. 53Θ§5–8, 25–9.
Tatsuka M. (2001): Maeda M, Ota T. Jpn J Cancer Res. 92, Nov, 1184–9.
Kikuchi Y, Sasa H, Kita T, Hirat J, Tode T, Nagata I. (1991): Anticancer Drugs. 2, 63–7.
Park EK, Choo MK, Kim EJ, Han MJ, Kim DH. (2003): Antiallergic activity of ginsenoside Rh2. Biol Pharm Bull. 26, 1581–4.
Ushio Sankawa, Chung ki, Byung Hoon han et al. (1982): Radioimmunoassay for the determination of ginseng saponin, ginsenoside Rg1. Chem. Pharm. Bull. 30, 1907–1910
Odani T, Tanizawa H, Takino Y. (1983): Chem Pharm Bull (Tokyo) 31, 292–8
Li W, Fitzloff JF. (2001): J Pharm Biomed Anal 25, 257–65
Wang H, Zou H, Kong L. (1999): J Chromatogr B Biomed Sei Appl 731, 403–9
Popovich DG, Kitts DD. (2004): Phytochemistry. 65, 337–44.
Yun TK, Lee YS, Lee YH. (2001): J Korean Med Sei. 16, Suppl: S6–18
Pang Huan, Wang Hai-lin, Fu Li et al. (2001): Acta Pharmaceutica Sinica, 36, 170–173
Chen SE, Sawchuk RJ, Staba EJ. American (1980): ginseng. III. Pharmacokinetics of ginsenosides in the rabbit. Eur J Drug Metab Pharmacokinet 5(3):161–8
Odani T, Tanizawa H, Takino Y. (1983): Chem Pharm Bull (Tokyo) Jan; 31, 292–8
Bae EA, Han MJ, Choo MK et al. (2002): Biol Pharm Bull 25, 58–63
Ota T, Maeda M, Odashima S. (1991): Mechanism of action of ginsenoside Rh2: uptake and metabolism of ginsenoside Rh2 by cultured B16 melanoma cells. J Pharm Sei Dec; 80(12): 1141–6.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xie, HT., Wang, GJ., Lv, H. et al. Development of a HPLC-MS assay for ginsenoside Rh2, a new anti-tumor substance from natural product and its pharacokinetic study in dogs. Eur. J. Drug Metab. Pharmacokinet. 30, 63–67 (2005). https://doi.org/10.1007/BF03226409
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03226409